AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

29 recruiting trials

for Acute Myeloid Leukemia (AML) in Remission

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission NCT05909293NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Venclexta 100 MG Oral Tablet Ziftomenib Maintenance Post Allo-HCT NCT06440135Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Columbus Massachusetts General Hospital ยท Tests: Ziftomenib Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial NCT07101588Phase 41 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Ruxolitinib, Decitabine Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT NCT05917405Phase 223 sites๐Ÿ“ Nantes๐Ÿ“ Amiens๐Ÿ“ Angers Nantes University Hospital ยท Tests: Fludarabine, Busulfan, ATG, Clofarabine Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients NCT04314219Phase 31 site๐Ÿ“ Riyadh King Faisal Specialist Hospital & Research Center ยท Tests: Cyclophosphamide 50mg, Methotrexate Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Andrew E. Place, MD ยท Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission NCT06824168Phase 264 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Daiichi Sankyo ยท Tests: Quizartinib High Dose, Quizartinib Low Dose Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX) NCT06045819n/a1 site๐Ÿ“ Caen University Hospital, Caen ยท Tests: Blood sampling for venetoclax drug dosage (venous puncture) Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880NA1 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi) Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning NCT03852407Phase 210 sites๐Ÿ“ Antwerp๐Ÿ“ Bruges๐Ÿ“ Brussels University of Liege ยท Tests: Thymoglobulin, Melphalan, Fludarabine, Cyclophosphamid UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746Phase 11 site๐Ÿ“ Wuhan Union Hospital, Tongji Medical College, Huazhong Universityโ€ฆ ยท Tests: umbilical cord derived mesenchymal stem cells exosomes (UCMSC-Exo) The Maintenance Treatment of "ITIVA" in AML Patients NCT06256627NA1 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: recombinant human interference'- ฮฑ- 1b, interleukin-2, thalidomide, Venentoclax and Azacitidine Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission. NCT07254312n/a1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Phase IB/II of CPX-351 for Relapse Prevention in AML NCT04990102Phase 1, Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ Hackensack๐Ÿ“ Philadelphia Georgetown University ยท Tests: CPX-351 XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia NCT06980155EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Jiao Tong University School of Medicine ยท Tests: Personalized neoantigen tumor vaccine, PD-1 inhibitor Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) NCT06462365Phase 15 sites๐Ÿ“ Duarte๐Ÿ“ Boston๐Ÿ“ Minneapolis Tr1X, Inc. ยท Tests: TRX103 AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission NCT05404906Phase 2, Phase 32 sites๐Ÿ“ Suzhou๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Azacitidine, Venetoclax, Supportive care Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML NCT06232694NA1 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;, Venetoclax (Venetoclax): 400mgโ€ฆ L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML NCT06788756Phase 2, Phase 328 sites๐Ÿ“ Birmingham๐Ÿ“ Miami๐Ÿ“ Augusta Moleculin Biotech, Inc. ยท Tests: Placebo in combination with Cytarabine Injection, Liposomal Annamycin Injection in combination with Cytarabine Injectioโ€ฆ Maintenance Venetoclax in AML Fit Patients NCT07244367NA2 sites๐Ÿ“ Sohag๐Ÿ“ Sohag Sohag University ยท Tests: SC cytarabine +Venetoclax Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML NCT07259707Phase 21 site๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: GVA + HDAC Consolidation & Gilteritinib Maintenance Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission NCT05010772Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Decitabine and Cedazuridine, Enasidenib, Gilteritinib, Ivosidenib, Venetoclax Registry of Older Patients With Cancer NCT01137825n/a7 sites๐Ÿ“ Boone๐Ÿ“ Chapel Hill๐Ÿ“ Greenville UNC Lineberger Comprehensive Cancer Center Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: biologic sample preservation procedure, cytology specimen collection procedure 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome NCT03670966Phase 1, Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, Cyclophosphamide, Total-Body Irradiation, Peripheral Blood Stem โ€ฆ Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML NCT06221683Phase 213 sites๐Ÿ“ Hefei๐Ÿ“ Hefei๐Ÿ“ Guangzhou Children's Hospital of Soochow University ยท Tests: Homoharringtonine, Cytarabine, Etoposide, Venetoclax, Mitoxantrone hydrochloride liposome Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML NCT05477589Phase 317 sites๐Ÿ“ Brussels๐Ÿ“ Brussels๐Ÿ“ Ghent Vastra Gotaland Region ยท Tests: busulfan, cyclophosphamide and melphalan, BuCyMel, clofarabine, fludarabine and busulfan, CloFluBu
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy